Medication History PBM Scenario 1 Contains Incorrect NDC mapping

17 views
Skip to first unread message

Ensora Test

unread,
Dec 29, 2025, 2:04:42 PM12/29/25
to eRxRTPB-testsuite
For Medication History Tests PBM Scenario 1 the medication history response includes a prescription on line 2437 for Glucophage 1000 mg oral tablet prescribed on 01/01/2025 but the NDC sent in MedicationDispensed.DrugCoded.ProductCode.Code is 00310075239 which maps to Crestor Crestor 20 mg oral tablet.

Please update this to the correct NDC value of 00087607111 (as is included for other dates in the response) as it is causing de-duping issues for the actual Crestor prescribed in the response for 01/01/2025.

Line 2437:
Current NDC sent for Glucophage 1000 mg oral tablet (incorrect): 00310075239
Updated NDC sent for Glucophage 1000 mg oral tablet (correct): 00087607111

IncorrectNDC.png

certification tool

unread,
Jan 2, 2026, 10:17:25 AMJan 2
to Ensora Test, eRxRTPB-testsuite

Hello,

Thank you for reaching out. We’ve received your email and we will get back to you shortly.

Sincerely,
The ONC ERX Validation Tool Team


--
You received this message because you are subscribed to the Google Groups "eRxRTPB-testsuite" group.
To unsubscribe from this group and stop receiving emails from it, send an email to erxrtpb-testsu...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/erxrtpb-testsuite/b55ee7f1-1da7-4ce0-9463-5064a7eaff93n%40googlegroups.com.

certification tool

unread,
Jan 12, 2026, 11:25:04 AMJan 12
to Ensora Test, eRxRTPB-testsuite
 Hello,

Thank you for reaching out and reporting this issue.

The NDC value for Glucophage 1000 mg oral tablet in Medication History Tests – PBM Scenario 1 has been corrected. The response now uses the approved NDC 00087607111, consistent with the other dates, which resolves the de-duplication issue you identified.

Please re-test and let us know if you have any additional questions or concerns.


Sincerely,
The ONC ERX Validation Tool Team
On Mon, Dec 29, 2025 at 2:04 PM Ensora Test <therah...@gmail.com> wrote:
--
Reply all
Reply to author
Forward
0 new messages